A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
Clinical trial NCT04876391 · COMPLETED
Trial details
- NCT number
- NCT04876391
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-24
- Primary completion
- 2024-04-26
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.